Condensed Balance Sheet (Unaudited)	Mar. 31, 2023 USD ($)
ASSETS
Current assets – prepaid expenses	$ 8,249
Deferred offering costs	248,147
TOTAL ASSETS	256,396
Current liabilities
Accrued offering costs and expenses	166,147
Promissory note – related party	71,452
Total Current Liabilities	237,599
Commitments and contingencies (Note 6)
SHAREHOLDERS’ EQUITY
Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding(1)	633	[1]
Additional paid-in capital	24,367
Accumulated deficit	(6,203)
TOTAL SHAREHODERS’ EQUITY	18,797
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 256,396

[1] Includes up to 825,000 Class B ordinary shares that were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 7). On May 24, 2023, the Company effected a share capitalization of 575,000, resulting in the Sponsor holding 6,325,000 founder shares. On May 30, 2023, as a result of the partial exercise of the over-allotment option, the Sponsor forfeited 75,000 of these shares and the remaining Class B ordinary shares are no longer subject to forfeiture. All share and per-share data has been retroactively restated to reflect the share capitalization (Note 8).